Skip to main content

Table 3 Recurrence pattern up to three years after surgery before and after propensity score matching

From: Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China

Variables

Original cohort

Matched cohort

nCRT (n = 97)

Non-nCRT (n = 116)

P

nCRT (n = 83)

Non-nCRT (n = 83)

P

Overall recurrence

26 (26.8)

32 (27.6)

0.898

23 (27.7)

21 (25.3)

0.725

Local recurrence

9 (9.3)

14 (12.1)

0.513

8 (9.6)

7 (8.4)

0.787

 Central pelvic

6 (6.2)

10 (8.6)

 

5 (6.0)

6 (7.2)

 

 Lateral pelvic

4 (4.1)

6 (5.2)

 

3 (3.6)

3 (3.6)

 

Distant metastasis

19 (19.6)

26 (22.4)

0.615

17 (20.5)

16 (19.3)

0.846

 Lung

12 (12.4)

15 (12.9)

 

10 (12.0)

11 (13.3)

 

 Liver

10 (10.3)

11 (9.5)

 

9 (10.8)

8 (9.6)

 

 Bone

6 (6.2)

8 (6.9)

 

5 (6.0)

5 (6.0)

 

 Peritoneum

1 (1.0)

3 (2.6)

 

1 (1.2)

2 (2.4)

 

 Lymph node

1 (1.0)

2 (1.7)

 

1 (1.2)

2 (2.4)

 
  1. Note: nCRT, neoadjuvant chemoradiotherapy